Agreement signedAgreed 20 Dec 2021
NightHawk Biosciences, Inc. /
Elusys Therapeutics, Inc.
NightHawk Biosciences, Inc. agrees to buy Elusys Therapeutics, Inc.
- Price
- $48.1m
- Stage
- Agreement signed
01 / BuyerNightHawk Biosciences, Inc.
02 / TargetElusys Therapeutics, Inc.
What happened
NightHawk Biosciences, Inc. agreed to acquire Elusys Therapeutics, Inc. for approximately $48.1 million, according to a filing dated June 6, 2022.
The source
Everything on this page comes from the source below.
01
Source · Source
NightHawk Biosciences, Inc. agrees to buy Elusys Therapeutics, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Announced
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly